Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in Sou...

por Koen, Anthonet L., Izu, Alane, Baillie, Vicky, Kwatra, Gaurav, Cutland, Clare L., Fairlie, Lee, Padayachee, Sherman D., Dheda, Keertan, Barnabas, Shaun L., Bhorat, Qasim Ebrahim, Briner, Carmen, Ahmed, Khatija, Bhikha, Sutika, Bhiman, Jinal N., du Plessis, Jeanine, Esmail, Aliasgar, Horne, Elizea, Hwa, Shi-Hsia, Oommen-Jose, Aylin, Lambe, Teresa, Laubscher, Matt, Malahleha, Mookho, Benade, Gabriella, McKenzie, Shakeel, Oelofse, Suzette, Patel, Faeezah, Pillay, Sureshnee, Rhead, Sarah, Rodel, Hylton, Taoushanis, Carol, Tegally, Houriiyah, Thombrayil, Asha, Villafana, Tonya L., Gilbert, Sarah, Pollard, Andrew J., Madhi, Shabir A.
Publicado 2023

Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B tr...

por Madhi, Shabir A, Moodley, Dhayendre, Hanley, Sherika, Archary, Moherndran, Hoosain, Zaheer, Lalloo, Umesh, Louw, Cheryl, Fairlie, Lee, Fouche, Leon Frederik, Masilela, Mduduzi S L, Singh, Nishanta, Grobbelaar, Coert, Ahmed, Khatija, Benadé, Gabriella, Bhikha, Sutika, Bhorat, As'ad Ebrahim, Bhorat, Qasim, Joseph, Natasha, Dheda, Keertan, Esmail, Aliasgar, Foulkes, Sharne, Goga, Ameena, Oommen Jose, Aylin, Kruger, Gertruida, Kalonji, Dishiki J, Lalloo, Natasha, Lombaard, Johan J, Lombard Koen, Anthonet, Kany Luabeya, Angelique, Mngqibisa, Rosie, Petrick, Friedrich G, Pitsi, Annah, Tameris, Michele, Thombrayil, Asha, Vollgraaff, Pieter-Louis, Cloney-Clark, Shane, Zhu, Mingzhu, Bennett, Chijioke, Albert, Gary, Faust, Emmanuel, Plested, Joyce S, Fries, Lou, Robertson, Andreana, Neal, Susan, Cho, Iksung, Glenn, Greg M, Shinde, Vivek
Publicado 2022